Amneal Pharmaceuticals to Buy Kashiv BioSciences, Touts Strong Preliminary Q1 Results and Biosimilar Push
Summary
Amneal Pharmaceuticals (NASDAQ:AMRX) outlined plans to acquire Kashiv BioSciences and reported preliminary first-quarter results during an investor call, with e...
Description
Amneal Pharmaceuticals (NASDAQ:AMRX) outlined plans to acquire Kashiv BioSciences and reported preliminary first-quarter results during an investor call, with e...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source